Compassionate use of tetrabenazine in the treatment of hyperkinesias.

Trial Profile

Compassionate use of tetrabenazine in the treatment of hyperkinesias.

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 03 Oct 2016

At a glance

  • Drugs Tetrabenazine (Primary)
  • Indications Hyperkinesia
  • Focus Adverse reactions; Expanded access; Therapeutic Use
  • Most Recent Events

    • 11 Feb 2016 Status changed from discontinued to recruiting as reported by ClinicalTrials.gov.
    • 01 Feb 2013 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 15 Feb 2012 Planned End Date changed from 1 Dec 2010 to 1 Dec 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top